Tirzepatide 30mg

Tirzepatide is a synthetic peptide that acts as a dual agonist of two key metabolic receptors:

• • GLP-1 (Glucagon-Like Peptide-1) receptor
  • GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor
• Structurally, it is a 39-amino acid peptide that combines elements of native GIP and GLP-1 sequences, modified to resist enzymatic degradation and extend its half-life (~5 days).
• Designed for once-weekly subcutaneous injection, it mimics natural gut hormones involved in regulating glucose and appetite.

Benefits:

Tirzepatide has shown clinically significant outcomes across several therapeutic areas:

• Type 2 Diabetes Management:
  • Improves glycemic control by enhancing insulin secretion and reducing glucagon levels.
  • Reduces HbA1c significantly, often more than GLP-1 receptor agonists alone.
• Weight Loss & Obesity Treatment:
  • Demonstrates substantial body weight reduction in both diabetic and non-diabetic individuals.
  • Acts on appetite regulation and delays gastric emptying, promoting a feeling of fullness.
• Cardiometabolic Improvements:
  • Modest improvements in lipid profiles, blood pressure, and inflammatory markers have been observed.
  • Ongoing studies are evaluating long-term cardiovascular benefits.
• Liver Health:
  • Early evidence suggests potential benefits in non-alcoholic fatty liver disease (NAFLD) due to weight reduction and insulin sensitivity improvements.